Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS). (Record no. 30291754)

MARC details
000 -LEADER
fixed length control field 01584 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518070329.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202105s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1365-2133
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/bjd.18696
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Thaçi, D
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20210514
245 00 - TITLE STATEMENT
Title Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS).
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The British journal of dermatology
Date of publication, distribution, etc. 08 2020
300 ## - PHYSICAL DESCRIPTION
Extent 265-275 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fumarates
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Psoriasis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quality of Life
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Severity of Illness Index
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pinter, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sebastian, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Termeer, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sticherling, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gerdes, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wegner, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Krampe, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bartz, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rausch, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mensch, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Eyerich, K
773 0# - HOST ITEM ENTRY
Title The British journal of dermatology
Related parts vol. 183
-- no. 2
-- p. 265-275
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/bjd.18696">https://doi.org/10.1111/bjd.18696</a>
Public note Available from publisher's website

No items available.